GMT Capital’s Outset Medical OM Stock Holding History

GMT Capital’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	98,108 +55,687	+131%	+$244K	0.02%	57
2026 Q1	$163K	Sell	42,421 -55,687	-57%	-$228K	0.01%	74
2025 Q4	$364K	Hold	98,108	–	–	0.02%	37
2025 Q3	$1.39M	Hold	98,108	–	–	0.06%	49
2025 Q2	$1.88M	Hold	98,108	–	–	0.08%	46
2025 Q1	$1.09M	Sell	98,108 -6	-0%	-$72	0.06%	55
2024 Q4	$1.63M	Hold	98,114	–	–	0.08%	43
2024 Q3	$996K	Hold	98,114	–	–	0.04%	55
2024 Q2	$5.67M	Buy	+98,114	New	+$4.81M	0.21%	32
2023 Q4	–	Sell	-36,052	Closed	-$5.88M	–	79
2023 Q3	$5.88M	Buy	+36,052	New	+$8.51M	0.22%	50

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

GMT Capital's OM Position: Q2 2026 in Review

GMT Capital increased its Outset Medical (OM) stake by 131% in Q2 2026, buying an estimated $244K and bringing the position to 98,108 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #57.

GMT Capital first reported a position in OM in Q3 2023 and has held it in 10 quarters since. The position peaked at $5.88M in Q3 2023. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

GMT Capital held 98,108 shares of Outset Medical worth $424K as of Q2 2026.
GMT Capital bought 55,687 Outset Medical shares in Q2 2026, an estimated $244K.
Outset Medical made up 0.02% of GMT Capital's portfolio in Q2 2026, its #57 holding.
GMT Capital first reported a position in Outset Medical in Q3 2023 and has held it in 10 quarters since.
GMT Capital's Outset Medical position peaked at $5.88M in Q3 2023.
93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on GMT Capital's 13F filing for Q2 2026, filed 14 Aug 2026.